Personalised Medicine in Cervical Cancer: Evaluating Therapy Resistance Through Multi‐Model Approaches.
- Published in:
- Cancer Medicine, 2025, v. 14, n. 13, p. 1, doi. 10.1002/cam4.70995
- By:
- Publication type:
- Article
Works by Eksteen, Carla
Results: 4
1
2
Inflammation and Tumor Progression: The Differential Impact of SAA in Breast Cancer Models.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 9, p. 654, doi. 10.3390/biology13090654
- By:
- Publication type:
- Article
3
A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2024, v. 31, p. 1, doi. 10.1177/10732748241261539
- By:
- Publication type:
- Article
4
Highlighting the role of CD44 in cervical cancer progression: immunotherapy's potential in inhibiting metastasis and chemoresistance.
- Published in:
- Immunologic Research, 2024, v. 72, n. 4, p. 592, doi. 10.1007/s12026-024-09493-6
- By:
- Publication type:
- Article